Company High-performance additives for sustainable plastics: Evonik invests in Interface Polymers Interface Polymers’ Polarfin® additives simplify the processing and recycling of plastics such as mixtures of polyethylene and polypropylene. ... MORE
Company Performance boost for electromobility: Evonik invests in battery expert SuperC The Chinese company is a technological leader in graphene materials that improve the range, robustness, charging speed, and service life of lithium-ion batteries. ... MORE
Company No opioids after surgery: Evonik invests in Allay Therapeutics Allay Therapeutics has developed an implant for treating pain after knee surgery. It is inserted directly into the knee and may relieve pain for up to three weeks ... MORE
Venture Capital Evonik Venture Capital invests in Japan for the first time Evonik Venture Capital has invested in Fund VIII of Global Brain Corporation, a Japanese venture capital company. The move marks Evonik’s first investment in the country. ... MORE
Company Evonik spends venture capital on sustainability funds Azolla Ventures and Chrysalix Evonik Venture Capital has invested in two sustainability funds: Azolla Ventures I and the Chrysalix Venture Capital’s Carbon Neutrality Fund. ... MORE
Portfolio Company Vivasure Medical Announces Series D Financing to Advance Portfolio of PerQseal Vessel Closure Devices Vivasure Medical announced the closing of the first tranche of €22 million ($23M) as part of its Series D financing round that could reach up to €52 million ($54M) in total. ... MORE
Venture Capital Evonik Venture Capital invests in Laxxon 3D printed tablets with better drug delivery improve patients’ health. ... MORE
Portfolio Company Citrine Informatics Wins Investment from Evonik Venture Capital Evonik invested in Citrine Informatics, provider of the Citrine Platform, a leading AI and smart data management software platform for materials and chemicals development. ... MORE
Portfolio Company In Ovo raises EUR 34M to end male chick culling Dutch AgTech scale-up closes 34M fund raise to accelerate its international growth and scale up plans. The funding is provided by impact investor ECBF and ABN AMRO and includes existing shareholders Evonik and VisVires New Protein. ... MORE
Portfolio Company Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics, announced the closing of a Seed 2 funding of 3.2 million Euro. Evonik Venture Capital participated as a new investor. ... MORE
Venture Capital Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery Evonik Venture Capital has invested in CircumFix Solutions, a U.S.-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. ... MORE
Venture Capital Alternative to animal testing: Evonik invests in Singapore start-up Evonik has invested in start-up Revivo BioSystems to support the development of a realistic 4D model of human skin that provides an alternative to animal testing. ... MORE
New Sustainability Tech Fund Investments with the primary objective to achieve CO2 mitigation by reducing and removing emissions ... MORE
What we are looking for Start-ups that are developing future-oriented technologies and disruptive business models. ... MORE
How we invest Our investments in outstanding business ideas are driven by financial and strategic objectives. ... MORE
Our portfolio Innovative start-ups that have the potential to become future industry leaders, combined with a set of diverse technology fund investments. ... MORE
Our Team Experts in start-up ecosystems across the globe with offices in Germany, USA and China. ... MORE
Do you know our Linkedin Channel? Follow Evonik Venture Capital to stay up to date on our latest investments, cooperations and news ... MORE
